Psychiatric NP Scope of Practice for ADHD in California

Look, I’m going to be straight with you about something most practice management consultants won’t say out loud: acquiring psychiatric patients through traditional marketing channels in 2026 is expensive, time-consuming, and frankly, a gamble most providers can’t afford to take.

If you’re a psychiatrist or PMHNP treating ADHD, you’ve probably heard the siren song of ‘build your own practice’ – invest in SEO, run Google Ads, get listed on directories, build your brand. It sounds empowering. But here’s what they don’t tell you: the real cost of acquiring a qualified ADHD patient through DIY marketing typically runs $200-500+ when you factor in everything. And that’s if you know what you’re doing.

Let me break down the actual economics of patient acquisition, and why platforms like Klarity Health represent a fundamentally different – and often smarter – business model for providers who want to see more patients without gambling thousands on marketing.

The True Cost of DIY Patient Acquisition (That Nobody Talks About)

When marketing agencies quote you ‘$50 cost per lead’ or consultants promise ‘affordable patient acquisition,’ they’re leaving out about 90% of the story. Here’s what actually goes into acquiring one booked ADHD patient through traditional channels:

SEO (The 6-12 Month Wait)
Sure, organic search traffic is ‘free’ once you rank. But getting there? You’re looking at:

• $2,000-5,000/month for a competent SEO agency (cheaper ones rarely deliver results in competitive markets like psychiatric care)
• 6-12 months minimum before you see meaningful traffic
• Another 3-6 months to optimize conversion from traffic to booked appointments
• Content creation, website optimization, technical SEO work
• Real timeline to ROI: 9-18 months. Real investment before first patient: $18,000-60,000.

Most solo practitioners or small groups don’t have the cash flow or patience for this timeline. And if you hire the wrong agency (which happens constantly), you’ve burned a year and tens of thousands of dollars with nothing to show for it.

Google Ads (The Expensive Click Lottery)
Mental health keywords are brutally expensive:

• Average cost per click for ‘ADHD psychiatrist near me’ or ‘ADHD medication online’: $15-40+
• Conversion rate from click to booked appointment: 2-5% if you’re good at this
• Math: To get one booked patient, you need 20-50 clicks = $300-2,000 per booked patient
• Plus monthly agency fees if you don’t run ads yourself ($1,500-3,000/month management)
• Plus 2-3 months of testing and optimization where most campaigns lose money
• High no-show rates from cold leads who clicked out of curiosity

And here’s the kicker: many of those clicks won’t even be qualified leads. Someone searching ‘ADHD medication’ might want a psychiatrist, or they might be researching for a family member, or comparison shopping, or not ready to book. Your $35 click just evaporated.

Directory Listings (The Hidden Monthly Drain)
Psychology Today, Zocdoc, Headway, and similar directories sound like a good deal:

• Psychology Today: ~$30/month, but you’re one profile among hundreds in any given city. Conversion rates are typically 1-3% of profile views.
• Zocdoc: Charges per booking ($35-100+ depending on specialty and market), BUT you also pay a monthly subscription to be listed. Total monthly cost with bookings can easily hit $500-1,500.
• Other networks: Similar models with monthly fees plus per-appointment charges or percentage cuts

Reality check: To get a consistent flow of 10-20 new ADHD patients per month from directories, you’re typically spending $800-2,000/month across multiple platforms, and you’re competing with every other provider in your area on the same page. The patients who do book are often price-shopping across multiple providers.

Total True Cost Per Acquired Patient Through Traditional Marketing
When you factor in:

• All the agency/consultant fees
• Ad spend (and the wasted spend during testing phases)
• Staff time handling inquiries and scheduling (many leads never convert)
• No-show rates from unqualified cold leads
• The months of investment before seeing any return

A realistic cost per acquired, qualified psychiatric patient is $200-500+ for most providers using traditional marketing channels. And that assumes you’re running effective campaigns – many providers spend more and get less.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Platform Model: Why Pay-Per-Appointment Changes Everything

Now let’s talk about how platforms like Klarity Health work, and why the economics are fundamentally different.

The Klarity Model (and Similar Platforms)
Klarity uses a pay-per-appointment model:

• No upfront marketing spend. You don’t pay until a patient books with you.
• No monthly subscription fees. You’re not paying $500-1,500/month whether you see patients or not.
• Pre-qualified patients. People on the platform have already indicated they’re looking for ADHD treatment, have checked insurance/payment options, and are ready to book.
• Built-in infrastructure. Telehealth platform, EHR, prescription workflows, insurance billing support – no separate software subscriptions needed.
• Standard listing fee per new patient lead. You pay a fee for each new patient who books with you (similar to Zocdoc’s model, but integrated into a full practice platform).

Why This Matters for Your Economics

Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient actually books an appointment with you. That’s guaranteed ROI vs. gambling on marketing channels that might not work.

Let’s compare two scenarios for a PMHNP wanting to build an ADHD practice:

Scenario A: DIY Marketing

• Month 1-3: Hire agency, build campaigns, optimize website, create content, test ads = $10,000+ invested, 0-3 patients booked
• Month 4-6: Start seeing some traction, spending $3,000/month on ongoing marketing = 5-10 patients per month
• Month 7-12: If everything goes right, spending $3,000-4,000/month on marketing = 15-20 patients per month
• Total first-year marketing investment: $40,000-50,000
• Patient volume: Highly variable, depends on your market, competition, and whether campaigns work
• Risk: High. You could spend $50,000 and end up with 10 patients/month if campaigns underperform.

Scenario B: Platform Model (Klarity)

• Month 1: Sign up, credentialing (1-2 weeks), set your schedule
• Month 2 onward: See patients as they book. Pay listing fee per new patient.
• First-year marketing investment: $0
• Patient volume: You control it by setting your availability. Want 20 patients/month? Set 20 slots. Want 40? Set 40 slots.
• Risk: Zero. You only pay when you see patients. If you need to reduce hours, you just adjust your schedule – no sunk costs.

For most providers, especially those starting out or scaling up, the platform model removes the financial risk entirely. You’re not betting $50,000 that your marketing will work – you’re paying a straightforward fee per patient, and the platform handles all the acquisition.

When DIY Marketing Makes Sense (And When It Doesn’t)

I’m not saying DIY marketing is always wrong. If you have:

• Deep pockets ($50,000+ to invest before seeing ROI)
• Time and patience (12-18 months to build momentum)
• Marketing expertise (or the budget to hire people who do)
• A unique brand or specialty that justifies the investment
• Long-term vision for building a large practice with multiple providers

…then investing in your own marketing infrastructure can eventually be cost-effective. Emphasis on eventually.

But if you’re:

• A new grad PMHNP trying to build a patient base quickly
• An established psychiatrist wanting to add telehealth without overhead
• Anyone who wants predictable patient flow without financial risk
• Scaling a practice and testing a new market or modality
• Simply trying to maximize clinical time instead of becoming a marketing expert

…then the platform model is almost always the smarter economic choice.

The Bottom Line: Economics of Scale vs. Economics of Certainty

Here’s the real insight: large telehealth platforms like Klarity can acquire patients more efficiently than individual providers because they have:

• Brand recognition (patients search for ‘Klarity’ or ‘telehealth ADHD’ and land on the platform)
• Marketing budgets that would bankrupt a solo provider
• Technology infrastructure that converts traffic efficiently
• Insurance contracts already in place (huge for patient flow)
• SEO authority – their domains rank for competitive keywords that would take you years to rank for

They can afford to spend $200-300 per patient acquisition at scale because they’re spreading that cost across thousands of providers and patients. You, as an individual provider, can’t achieve that efficiency.

So instead of competing with them (spending $200-500 per patient), you partner with them and pay a listing fee that’s essentially sharing in their economies of scale. You get their patient flow, their brand, their infrastructure – without the upfront investment or ongoing risk.

What This Means for Your ADHD Practice in 2026

If you’re treating ADHD patients via telehealth, you have three realistic paths:

Path 1: Go All-In on DIY Marketing

• High upfront cost, high risk, long timeline
• Best for: Providers with capital and patience who want to own their entire practice infrastructure
• Realistic outcome: 12-18 months to profitability, $50,000+ invested, success highly variable

Path 2: Use a Platform Like Klarity as Your Primary Patient Source

• Zero upfront cost, zero risk, immediate patient flow
• Best for: Providers who want to maximize clinical time, new grads, anyone scaling quickly
• Realistic outcome: See patients within 2-3 weeks of credentialing, pay per appointment, predictable income

Path 3: Hybrid Approach

• Use platform for immediate volume while building your own marketing over time
• Best for: Providers with long-term vision but need cash flow now
• Realistic outcome: Stable income from platform while DIY channels ramp up over 12+ months

For most providers reading this, Path 2 or Path 3 is the smart play.

ADHD Prescribing Regulations: What You Need to Know Before Joining Any Platform

Okay, we’ve covered the economics. Now let’s talk about the regulatory side, because none of this matters if you can’t legally prescribe ADHD medications via telehealth in your state.

The good news: as of 2026, telehealth prescribing for ADHD is legal and protected under federal law through December 31, 2026, thanks to the DEA’s fourth extension of COVID-era flexibilities. The less good news: after 2026, new rules are coming, and state-level regulations vary significantly.

Let me walk you through what you need to know, state by state, focusing on the six states where most Klarity providers practice: California, Texas, Florida, New York, Pennsylvania, and Illinois.

Federal Rules: The DEA Extension Through 2026

Here’s the current federal landscape:

Ryan Haight Act (The Baseline)
Normally, the Ryan Haight Act requires an in-person medical evaluation before prescribing any controlled substance (including ADHD medications like Adderall, Ritalin, Vyvanse). This was a major barrier to telehealth ADHD care before 2020.

COVID-Era Flexibility (Still Active)
In March 2020, the DEA waived the in-person requirement under public health emergency powers. That waiver has been extended four times and currently runs through December 31, 2026. This means:

• You CAN prescribe Schedule II stimulants (Adderall, Ritalin, etc.) via telehealth to new patients
• You do NOT need an initial in-person visit (though some states may require it – see below)
• You MUST conduct an appropriate evaluation via live audio-video (not just a phone call or questionnaire)
• You MUST follow all other controlled substance prescribing rules (DEA registration, state PDMP checks, e-prescribing, etc.)

What’s Coming in 2027: The DEA’s Permanent Rules

The DEA is working on permanent regulations that will likely include:

• Telemedicine Special Registration: A new DEA registration type specifically for providers who want to prescribe controlled substances via telehealth without an in-person exam
• Mandatory PDMP checks: Nationwide prescription monitoring database queries before prescribing
• Stricter identity verification: Ensuring the patient is who they claim to be during video visits
• Platform registration requirements: Telehealth companies will need to register with the DEA

The DEA’s approach appears to be preserving telehealth access while adding guardrails to prevent abuse. For responsible providers, these changes shouldn’t be barriers – just additional compliance steps.

Action item: If you’re planning to prescribe ADHD meds via telehealth long-term, expect to obtain a Telemedicine Special Registration when it becomes available (likely 2027). Platforms like Klarity will guide you through this process.

State-by-State Breakdown: Where You Can (and Can’t) Prescribe ADHD Meds via Telehealth

California: Progressive and Permissive

Can you prescribe ADHD meds via telehealth? YES

California is one of the most telehealth-friendly states:

• No state-level in-person exam requirement
• Telehealth evaluation meets the legal standard for prescribing
• No special restrictions on controlled substance prescribing via telehealth

Scope of Practice:

• Psychiatrists (MD/DO): Full authority. No restrictions.
• PMHNPs: California is transitioning to Full Practice Authority (FPA) for experienced NPs. By 2026, NPs with 3+ years experience can prescribe independently, including ADHD meds. New grad NPs need a supervising physician initially.

Key Requirements:

• Must check CURES (CA’s prescription monitoring database) before initial Schedule II prescription and every 4 months for ongoing treatment
• Must use electronic prescribing for controlled substances
• Must be licensed in California (no compact or telehealth-only license available)

Bottom line for CA providers: This is a great state for telehealth ADHD practice. Just stay on top of PDMP checks and make sure you’re credentialed in CA.

Texas: Restrictive for NPs, Open for Psychiatrists

Can you prescribe ADHD meds via telehealth? YES (but with major caveats for NPs)

Texas allows telehealth for mental health treatment, but has a critical restriction:

The Texas NP Problem:Nurse practitioners and PAs in Texas CANNOT prescribe Schedule II controlled substances in outpatient settings. Period. The only exceptions are:

• Hospital inpatient orders (≥24 hour stays)
• Hospice patients
• Emergency department orders

This means:

• A PMHNP in Texas cannot prescribe Adderall, Ritalin, or any ADHD stimulant to outpatient telehealth patients
• Only psychiatrists (MD/DO) can prescribe ADHD medications in outpatient settings in Texas

If you’re an NP wanting to treat ADHD in Texas via telehealth, you MUST have a physician collaborator who actually writes the prescriptions. On platforms like Klarity, this typically means Texas-licensed psychiatrists handle ADHD prescribing, or NPs work in tandem with physician oversight.

Scope of Practice:

• Psychiatrists (MD/DO): Full authority for telehealth ADHD prescribing
• PMHNPs: Can evaluate and manage ADHD patients, but cannot prescribe stimulants independently

Key Requirements:

• Must be licensed in Texas (or use IMLC for physicians)
• Must use electronic prescribing for all controlled substances (mandatory since 2021)
• PDMP checks are required for opioids, benzos, barbiturates, and carisoprodol (not explicitly required for stimulants, but recommended)

Bottom line for TX providers: Great state for psychiatrists. Challenging for NPs who want to prescribe ADHD meds – you’ll need physician partnership.

Florida: The ‘Psychiatric Disorder’ Exception

Can you prescribe ADHD meds via telehealth? YES (explicitly permitted by law)

Florida statute §456.47 contains a specific carve-out: telehealth providers CAN prescribe Schedule II controlled substances for treatment of ‘psychiatric disorders.’ ADHD qualifies.

This makes Florida one of the clearest states legally:

• No in-person exam required by state law for mental health prescribing
• Explicit statutory permission to prescribe ADHD medications via telehealth
• Out-of-state providers can register for a Florida telehealth registration (without full FL license) and still prescribe for mental health

Scope of Practice:

• Psychiatrists (MD/DO): Full authority
• PMHNPs: Can prescribe ADHD medications BUT must practice under a protocol with a supervising psychiatrist. Florida’s 7-day limit on Schedule II prescriptions does NOT apply to psychiatric nurse practitioners treating mental health conditions, so you can prescribe full monthly supplies.

Key Requirements:

• Must check E-FORCSE (Florida’s PDMP) before prescribing controlled substances for patients ≥16 years old
• Must use electronic prescribing
• Must obtain patient consent for telehealth (document it)
• Out-of-state providers: Can use Florida’s telehealth registration system (must meet eligibility criteria – clean license, malpractice insurance, etc.)

Bottom line for FL providers: One of the best states for telehealth ADHD practice. Clear legal framework, explicit permission, and the out-of-state registration option makes it accessible for providers nationwide.

New York: Recently Aligned with Federal Law

Can you prescribe ADHD meds via telehealth? YES (as of May 2025)

New York State updated its regulations in May 2025 to explicitly align with federal telehealth rules. Prior to this, NY had a state-level barrier that mirrored the Ryan Haight Act.

Current Rules (as of 2025-2026):

• Controlled substances can be prescribed via telehealth when consistent with federal law
• Since federal law currently allows it (through Dec 2026), New York allows it
• Once DEA implements permanent rules, NY will adopt those requirements

Scope of Practice:

• Psychiatrists (MD/DO): Full authority
• PMHNPs: Can prescribe Schedule II-V controlled substances. Experienced NPs (3,600+ hours) can practice independently without written collaborative agreement. No quantity limits on stimulant prescriptions for NPs.

Key Requirements:

• Must check I-STOP/PMP registry before prescribing any Schedule II, III, or IV controlled substance (mandatory for stimulants)
• Must use electronic prescribing for all controlled substances (required since 2016)
• 90-day supply option: NY allows up to 90-day prescriptions for ADHD stimulants if you indicate diagnosis code ‘B’ (ADHD/minimal brain dysfunction) on the prescription – useful for stable patients
• Must be licensed in New York (no compact available; full license required)

Bottom line for NY providers: Great state for telehealth ADHD care, especially after the 2025 regulatory update. Just stay on top of PDMP checks (NY is strict about this) and use e-prescribing.

Pennsylvania: Collaborative Model Required for NPs

Can you prescribe ADHD meds via telehealth? YES

Pennsylvania has no state-level prohibition on telehealth prescribing of controlled substances. The state medical boards allow telemedicine practice under the same standard of care as in-person.

Scope of Practice:

• Psychiatrists (MD/DO): Full authority. Can use IMLC to expedite licensure if from another compact state.
• PMHNPs: MUST have a collaborative agreement with a physician. Limited to 30-day supply of Schedule II controlled substances; any continuation beyond 30 days requires physician approval (i.e., the physician reviews the case and green-lights ongoing therapy).

Key Requirements:

• Must check PA PDMP before initial prescription of any controlled substance (and periodically thereafter, especially for opioids/benzos – best practice is to check for stimulants each time)
• Must use electronic prescribing for controlled substances (mandatory since 2019)
• NPs: Physician collaborator must be available for consultation and must review Schedule II prescribing monthly

Bottom line for PA providers: Good state for telehealth ADHD care, but NPs need physician oversight and are limited to 30-day supplies. If you’re a PMHNP in PA, you’ll work in tandem with a psychiatrist on stimulant management.

Illinois: Full Practice Authority Available (With Conditions)

Can you prescribe ADHD meds via telehealth? YES

Illinois allows telehealth prescribing of controlled substances under standard-of-care guidelines. No state-level in-person exam requirement beyond federal law.

Scope of Practice (This is where IL gets interesting):

Illinois has a two-tier system for NPs:

Tier 1: APRNs Under Collaboration

• MUST have written collaborative agreement with physician
• Can prescribe Schedule II controlled substances for 30-day supply only
• Any continuation of Schedule II beyond 30 days requires physician approval
• Physician must review APRN’s Schedule II prescribing monthly

Tier 2: Full Practice Authority (FPA) APRNs

• Available to NPs with 4,000+ hours of practice under collaboration + 250 hours of additional training/CE
• Can prescribe independently, including stimulants, WITHOUT physician collaboration
• Exception: If prescribing Schedule II narcotic drugs (opioids) or benzodiazepines, must have a ‘consultation relationship’ with a physician (monthly consults)
• Key point: Stimulants are Schedule II non-narcotic substances, so the consultation requirement does NOT apply to ADHD medications

What this means: An Illinois PMHNP with Full Practice Authority can prescribe Adderall independently via telehealth, with no quantity limits and no mandatory physician involvement (for ADHD specifically).

Scope of Practice:

• Psychiatrists (MD/DO): Full authority
• PMHNPs: Path to independence available; great for experienced NPs who want autonomy

Key Requirements:

• Must hold Illinois controlled substance license (in addition to DEA registration)
• Must check IL PDMP (AWARxE) – required for opioids and initial benzo prescriptions; recommended for stimulants
• Must use electronic prescribing
• Must be licensed in Illinois

Bottom line for IL providers: One of the better states for NP autonomy in ADHD care, IF you qualify for FPA. New NPs will need physician collaboration initially. Very telehealth-friendly overall.

State Comparison Table: ADHD Telehealth Prescribing at a Glance

What This Means for Your Practice: Choosing the Right Platform

If you’re a psychiatrist or PMHNP treating ADHD, here’s your decision framework:

You should join a telehealth platform like Klarity if:

• You want immediate patient volume without marketing investment
• You want to avoid the financial risk of DIY patient acquisition
• You value predictable income over building your own brand
• You’re early in your career and need steady cash flow
• You want to test telehealth or a new market without committing to overhead
• You’re licensed (or willing to get licensed) in telehealth-friendly states like CA, FL, NY, PA, IL

You should invest in DIY marketing if:

• You have $50,000+ and 12-18 months to build your own patient acquisition channels
• You have marketing expertise or can hire competent help
• You want to own your entire practice infrastructure and brand
• You’re building a multi-provider practice where the investment pays off across multiple clinicians
• You’re in a niche market where you can differentiate from platforms

You should do both (hybrid approach) if:

• You need cash flow now but have long-term vision for your own practice
• You want the safety net of platform volume while building your brand
• You’re testing different markets or modalities

Joining Klarity: What to Expect

If you decide the platform model makes sense for your ADHD practice, here’s what the process looks like:

1. Application & Credentialing (1-3 weeks)

• Submit application with your credentials (license, DEA, malpractice insurance)
• Klarity verifies your credentials and handles insurance credentialing if you see insured patients
• Background check and reference verification

2. Onboarding & Training (1 week)

• Platform walkthrough: EHR, telehealth system, e-prescribing workflow
• State-specific compliance training (prescribing rules, PDMP checks, documentation standards)
• Scheduling setup: You control your availability and patient volume

3. Start Seeing Patients (Week 3-4)

• Patients matched to you based on your specialty, availability, and licensure
• Pre-qualified patients book appointments directly in your calendar
• Platform handles intake, insurance verification, payment processing
• You conduct evaluation via HIPAA-compliant video
• E-prescribe directly from the platform (integrated EPCS)
• Platform provides clinical support, prescription monitoring tools, and compliance reminders

4. Get Paid

• Standard listing fee per new patient (exact fees disclosed during onboarding)
• No monthly minimums, no upfront costs
• Earnings processed regularly (weekly or biweekly depending on setup)
• 1099 independent contractor model

5. Scale As You Want

• Want more volume? Increase your availability.
• Need to reduce hours? Adjust your schedule.
• Want to practice in multiple states? Get licensed and add states to your profile.
• No long-term contracts, no penalties for adjusting volume

The Bottom Line: Economics and Regulations Working For You

Here’s the reality of ADHD telehealth practice in 2026:

The economics favor platforms for most providers who want to maximize clinical time and minimize financial risk. The cost of acquiring patients on your own is $200-500+ per patient when you account for all the hidden costs. Platforms can do it more efficiently at scale and pass those savings to you through a transparent per-appointment fee model.

The regulations are evolving but permissive through at least December 2026, with most states allowing telehealth ADHD prescribing under straightforward rules. The key is understanding your state’s specific requirements (especially NP scope of practice limitations in Texas, Pennsylvania, and Illinois).

The opportunity is massive. ADHD is underdiagnosed, undertreated, and millions of patients are looking for accessible care via telehealth. Whether you’re a new PMHNP trying to build a practice or an established psychiatrist looking to add telehealth without overhead, there’s never been a better time to treat ADHD patients virtually.

The question isn’t ‘Should I do telehealth ADHD care?’ (the answer is almost certainly yes). The question is: ‘What’s the smartest way to acquire patients without gambling my savings?’

For most providers reading this, the answer is joining a platform that’s already solved patient acquisition, regulatory compliance, and practice infrastructure – so you can focus on what you do best: treating patients.

Frequently Asked Questions

Can I really prescribe Adderall via telehealth without ever seeing the patient in person?

Yes, through December 31, 2026, under the DEA’s extended flexibilities. You must conduct an appropriate evaluation via live audio-video and follow all other prescribing rules (PDMP checks, e-prescribing, etc.). After 2026, new DEA rules will likely require a Telemedicine Special Registration, but in-person exams are not expected to be mandatory.

What happens in 2027 when the DEA extension expires?

The DEA is finalizing permanent rules that will preserve telehealth prescribing with added safeguards (special registration, mandatory PDMP checks, identity verification). Platforms like Klarity will guide providers through any new requirements. The direction is toward maintaining telehealth access, not rolling it back.

I’m a PMHNP in Texas. Can I join Klarity to treat ADHD patients?

Yes, but you’ll need to work under physician oversight for prescribing stimulants (since Texas law prohibits NPs from prescribing Schedule II in outpatient settings). Klarity typically pairs Texas NPs with Texas-licensed psychiatrists for ADHD medication management.

Do I need separate licenses for each state where I see patients?

Yes. You must be licensed in the state where the patient is located at the time of the appointment. Some states (like Florida) offer out-of-state telehealth registration as an alternative to full licensure. Physicians can use the Interstate Medical Licensure Compact (IMLC) to expedite multi-state licensing.

How much does it actually cost to acquire a patient through Google Ads?

For mental health keywords (especially ADHD-related searches), cost per click is $15-40+. With a 2-5% conversion rate from click to booked appointment, you’re looking at $300-2,000 per booked patient, plus agency management fees if you don’t run ads yourself. Most solo providers spend $200-500+ total per acquired patient when factoring in all costs.

What’s the difference between Klarity’s model and Psychology Today or Zocdoc?

Psychology Today charges a monthly listing fee (~$30/month) but provides no infrastructure – you’re just a profile competing with hundreds of others. Zocdoc charges per booking ($35-100+) PLUS a monthly subscription. Klarity uses a similar pay-per-appointment model but includes the full practice infrastructure: telehealth platform, EHR, e-prescribing, insurance credentialing, compliance tools, and pre-qualified patient matching. You’re not just getting a listing – you’re getting a complete virtual practice setup.

Is SEO worth it for a private practice?

SEO can be worth it if you have $50,000+ and 12-18 months to invest before seeing meaningful returns. For most solo practitioners or small groups, the timeline and cost are prohibitive. Platforms that already have SEO authority (like Klarity) can rank for competitive keywords that would take individual providers years to achieve. It’s a classic ‘build vs. buy’ decision – and for most providers, buying access to an established platform is smarter than building from scratch.

Will I make less money on a platform vs. my own practice?

Not necessarily. While you pay a listing fee per patient, you also avoid:

• $3,000-5,000/month marketing spend
• $200-500+ per patient acquisition cost
• Software subscriptions (EHR, telehealth, e-prescribing)
• Staff costs (administrative, billing, scheduling)
• Months of ramp-up time before seeing patients

Most providers on platforms see higher net income in the first 12-18 months compared to building from scratch, because they see more patients faster with zero upfront investment. Long-term, owning your practice can be more profitable – but only if you successfully build a patient base and maintain volume.

Can I do both – use a platform AND build my own practice?

Absolutely. Many providers use the hybrid approach: join a platform for immediate cash flow and stable patient volume, while building their own marketing and patient base over time. Once your DIY channels are generating consistent patients (12-18 months later), you can choose to reduce platform volume or continue both. There’s no reason it has to be either/or.

Ready to Start Seeing ADHD Patients This Month?

If the economics and regulations we’ve covered make sense for your situation, here’s your next step:

Apply to Join Klarity’s Provider Network

• No upfront costs or monthly fees
• See pre-qualified ADHD patients in 2-3 weeks
• Full telehealth platform, EHR, and e-prescribing included
• Compliance support for state-specific prescribing rules
• Control your schedule and patient volume
• Get paid per appointment – no marketing gamble required

You became a provider to treat patients, not to become a marketing expert. Let Klarity handle patient acquisition so you can focus on what you do best.

Sources and References

The regulatory information in this article was compiled from official government sources, state statutes, and medical board guidance current as of February 2026. Key sources include:

1. **

Source:

• https://www.healthcaredive.com/news/dea-hhs-extend-telehealth-controlled-substance-prescriptions-flexibilities-fourth-time/808735/#:~:text=,II%20to%20Schedule%20V%20drugs
• https://www.healthcaredive.com/news/dea-hhs-extend-telehealth-controlled-substance-prescriptions-flexibilities-fourth-time/808735/#:~:text=,to%20hash%20out%20permanent%20regulations
• https://rxagent.co/blog/np-prescribing-authority#:~:text=Proposed%20DEA%20rules%20create%20a,for%20telemedicine%20prescribing
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=there%20any%20settings%20other%20than,may%20prescribe%20Schedule%20II%20controlled
• https://www.ninthdistrict.org/home/2025/05/30/nysdoh-issues-guidance-on-prescribing-controlled-substances-via-telehealth#:~:text=as%20such%20terms%20are%20defined,the%20use%20of%20electronic%20prescribing
• https://www.pacodeandbulletin.gov/secure/pacode/data/049/chapter21/chap21toc.html#:~:text=,
• https://www.ilga.gov/agencies/JCAR/EntirePart?titlepart=06801300#:~:text=match%20at%20L5536%203,collaborating%20physician%20or%20podiatric%20physician
• https://rxagent.co/blog/np-prescribing-authority#:~:text=However%2C%20,3
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care